The commercial roll out of FlowOx™ has gained substantial momentum!

FlowOx™ now available in >25 countries around the globe

Otivio has developed FlowOx™ for patients suffering from the effects of Peripheral Artery Disease (PAD) such as leg pain and chronic wounds. Long-term testing records indicate an improvement in blood circulation, reduction in pain, acceleration in wound healing and prevention of amputation. FlowOx is a non-invasive, non-sterile device that enables patients to comfortably treat themselves in their own home environment.

Based on FlowOx’ unique value proposition, the commercial roll out over the past 12 months has gained substantial momentum: from a standing start with only one distributor in spring 2022, Otivio has signed several additional distributors in the past 12 months making FlowOx available in more than 20 countries globally with current focus on Europe and Asia Pacific. And the distribution network is steadily increasing…

The reception for FlowOx is very positive and there is unanimous and universal support to the FlowOx proposition from Health Care Professionals, commercial partners and users. What is particularly liked is the fact that FlowOx is a non-invasive, easy to use device and can be applied in a home setting as well as in a professional healthcare setting.

Going forward, Otivio remains committed to bringing FlowOx and its revolutionary Intermittent Negative Pressure (INP) technology to patients in need around the world.